These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 20360322)

  • 21. Functional MRI in attention-deficit hyperactivity disorder: evidence for hypofrontality.
    Zang YF; Jin Z; Weng XC; Zhang L; Zeng YW; Yang L; Wang YF; Seidman LJ; Faraone SV
    Brain Dev; 2005 Dec; 27(8):544-50. PubMed ID: 15876503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurobiological disturbances in callous-unemotional youths.
    Dolan M
    Am J Psychiatry; 2008 Jun; 165(6):668-70. PubMed ID: 18519530
    [No Abstract]   [Full Text] [Related]  

  • 23. Zeroing in on attention deficit disorder.
    Health News; 1999 Feb; 5(2):7. PubMed ID: 9972114
    [No Abstract]   [Full Text] [Related]  

  • 24. The neural correlates of attention deficit hyperactivity disorder: an ALE meta-analysis.
    Dickstein SG; Bannon K; Castellanos FX; Milham MP
    J Child Psychol Psychiatry; 2006 Oct; 47(10):1051-62. PubMed ID: 17073984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proton magnetic resonance spectroscopy and cognitive function in pediatric attention-deficit/hyperactive disorder.
    Sparkes SJ; MacMaster FP; Carrey NC
    Brain Cogn; 2004 Mar; 54(2):173-5. PubMed ID: 15025062
    [No Abstract]   [Full Text] [Related]  

  • 26. The neurology of attention deficit/hyperactivity disorder.
    Curatolo P
    Brain Dev; 2005 Dec; 27(8):541-3. PubMed ID: 16310587
    [No Abstract]   [Full Text] [Related]  

  • 27. Prefrontal and executive attention network lesions and the development of attention-deficit/hyperactivity symptomatology.
    Max JE; Manes FF; Robertson BA; Mathews K; Fox PT; Lancaster J
    J Am Acad Child Adolesc Psychiatry; 2005 May; 44(5):443-50. PubMed ID: 15843766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stimulants: Therapeutic actions in ADHD.
    Arnsten AF
    Neuropsychopharmacology; 2006 Nov; 31(11):2376-83. PubMed ID: 16855530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroeconomics of attention-deficit/hyperactivity disorder: differential influences of medial, dorsal, and ventral prefrontal brain networks on suboptimal decision making?
    Sonuga-Barke EJ; Fairchild G
    Biol Psychiatry; 2012 Jul; 72(2):126-33. PubMed ID: 22560046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [High prevalence of ADDH: disturbed children or disordered society?].
    Narbona J
    Rev Neurol; 2001 Feb 1-15; 32(3):229-31. PubMed ID: 11310274
    [No Abstract]   [Full Text] [Related]  

  • 31. Response inhibition in adolescents diagnosed with attention deficit hyperactivity disorder during childhood: an event-related FMRI study.
    Schulz KP; Fan J; Tang CY; Newcorn JH; Buchsbaum MS; Cheung AM; Halperin JM
    Am J Psychiatry; 2004 Sep; 161(9):1650-7. PubMed ID: 15337656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Task-specific hypoactivation in prefrontal and temporoparietal brain regions during motor inhibition and task switching in medication-naive children and adolescents with attention deficit hyperactivity disorder.
    Smith AB; Taylor E; Brammer M; Toone B; Rubia K
    Am J Psychiatry; 2006 Jun; 163(6):1044-51. PubMed ID: 16741205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of stimulants for attention deficit hyperactivity disorder: FOR.
    Coghill D
    BMJ; 2004 Oct; 329(7471):907-8. PubMed ID: 15485975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychostimulants as cognitive enhancers: the prefrontal cortex, catecholamines, and attention-deficit/hyperactivity disorder.
    Berridge CW; Devilbiss DM
    Biol Psychiatry; 2011 Jun; 69(12):e101-11. PubMed ID: 20875636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of stimulants for attention deficit hyperactivity disorder: AGAINST.
    Marcovitch H
    BMJ; 2004 Oct; 329(7471):908-9. PubMed ID: 15485976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Attention deficit with or without hyperactivity disorder: evaluation and drug therapy].
    Beaulieu MJ
    Perspect Infirm; 2012; 9(1):21-3. PubMed ID: 22295448
    [No Abstract]   [Full Text] [Related]  

  • 37. Association of adult attention deficit hyperactivity disorder subtypes and response to methylphenidate HCL treatment: A magnetic resonance spectroscopy study.
    Unal GA; Kenar AN; Herken H; Kiroglu Y
    Neurosci Lett; 2015 Sep; 604():188-92. PubMed ID: 26257254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anatomic brain abnormalities in monozygotic twins discordant for attention deficit hyperactivity disorder.
    Castellanos FX; Sharp WS; Gottesman RF; Greenstein DK; Giedd JN; Rapoport JL
    Am J Psychiatry; 2003 Sep; 160(9):1693-6. PubMed ID: 12944348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Psychostimulant treatment for ADHD is modulated by prefrontal cortex manipulation.
    Tang A; Wanchoo SJ; Swann AC; Dafny N
    Brain Res Bull; 2009 Dec; 80(6):353-8. PubMed ID: 19729055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dysfunctional attentional networks in children with attention deficit/hyperactivity disorder: evidence from an event-related functional magnetic resonance imaging study.
    Konrad K; Neufang S; Hanisch C; Fink GR; Herpertz-Dahlmann B
    Biol Psychiatry; 2006 Apr; 59(7):643-51. PubMed ID: 16197925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.